Wolf Greenfield Ranked Tier One in 2025 LMG Life Sciences Guide
Wolf Greenfield has once again been recognized among the leading law firms in the life sciences sector. In the 2025 edition of LMG Life Sciences, the firm earned Tier One rankings in both Patent Prosecution and Patent Strategy & Management.
In addition to firmwide recognition, eight Wolf Greenfield attorneys were honored individually as Life Science Stars for their outstanding work:
- C. Hunter Baker, Chair, Pharmaceutical Practice
- Heather J. DiPietrantonio, Shareholder, Biotechnology Practice
- Edward R. Gates, Shareholder, Biotechnology Practice & Pharmaceutical Practice
- Helen C. Lockhart, Shareholder, Biotechnology Practice
- Timothy J. Oyer, Shareholder, Chemical & Materials Technologies Practice
- Maryanne Trevisan, Co-chair, Biotechnology Practice
- Patrick R. H. Waller, Co-chair, Biotechnology Practice
- Daniel W. Young, Shareholder, Biotechnology Practice
Wolf Greenfield has long been recognized as a leader in life sciences intellectual property. In 2025, Patexia ranked the firm the second most active law firm for biotech patent prosecution, marking the fifth consecutive year that the Biotechnology Practice has placed in the top five nationwide based purely on statistics. The firm is also nationally ranked for Life Sciences IP by Managing IP, while Chambers and Partners highlights Wolf Greenfield’s “strong reputation for its deep bench of life sciences specialists.” In addition, The Legal 500 individually ranks three of the firm’s biotechnology attorneys for their outstanding work in the field.
The LMG Life Sciences rankings are determined through extensive research, including analysis of case evidence and feedback from clients and peers across the legal industry.